These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25254621)

  • 1. Hormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies.
    Mendoza N; Simoncini T; Genazzani AD
    Gynecol Endocrinol; 2014; 30(12):850-60. PubMed ID: 25254621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls.
    Lanzo E; Monge M; Trent M
    Pediatr Ann; 2015 Sep; 44(9):e223-30. PubMed ID: 26431241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Syndrome: Polycystic Ovary Syndrome.
    Mortada R; Williams T
    FP Essent; 2015 Aug; 435():30-42. PubMed ID: 26280343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic approach for metabolic disorders and infertility in women with PCOS.
    Morgante G; Massaro MG; Di Sabatino A; Cappelli V; De Leo V
    Gynecol Endocrinol; 2018 Jan; 34(1):4-9. PubMed ID: 28850273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural molecules for the therapy of hyperandrogenism and metabolic disorders in PCOS.
    Cappelli V; Musacchio MC; Bulfoni A; Morgante G; De Leo V
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):15-29. PubMed ID: 28724177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
    Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
    Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
    Amiri M; Kabir A; Nahidi F; Shekofteh M; Ramezani Tehrani F
    Eur J Contracept Reprod Health Care; 2018 Feb; 23(1):64-77. PubMed ID: 29457756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy complications in women with polycystic ovary syndrome.
    Palomba S; de Wilde MA; Falbo A; Koster MP; La Sala GB; Fauser BC
    Hum Reprod Update; 2015; 21(5):575-92. PubMed ID: 26117684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic therapy of polycystic ovary syndrome.
    Dronavalli S; Ehrmann DA
    Clin Obstet Gynecol; 2007 Mar; 50(1):244-54. PubMed ID: 17304039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best methods for identification and treatment of PCOS.
    Artini PG; Di Berardino OM; Simi G; Papini F; Ruggiero M; Monteleone P; Cela V
    Minerva Ginecol; 2010 Feb; 62(1):33-48. PubMed ID: 20186113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options of polycystic ovary syndrome in adolescence.
    Zapanti E; Kiapekou E; Loutradis D
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic manifestations of women with polycystic ovary syndrome.
    Chen MJ; Ho HN
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():119-128. PubMed ID: 27107966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine characteristics of polycystic ovary syndrome (PCOS).
    Szilágyi A; Szabó I
    Indian J Exp Biol; 2003 Jul; 41(7):694-700. PubMed ID: 15255372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the myo-inositol-monacolin K association on hyperandrogenism and on the lipidic metabolism parameters in PCOS women].
    Musacchio MC; Cappelli V; Di Sabatino A; Morgante G; De Leo V
    Minerva Ginecol; 2013 Feb; 65(1):89-97. PubMed ID: 23412023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
    Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
    Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
    Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
    Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.